Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
52 巻, 15 号
選択された号の論文の24件中1~24を表示しています
ORIGINAL ARTICLES
  • Hironori Tsuzura, Takuya Genda, Shunsuke Sato, Katsuharu Hirano, Yoshi ...
    2013 年 52 巻 15 号 p. 1665-1673
    発行日: 2013年
    公開日: 2013/08/01
    ジャーナル オープンアクセス
    Objective Genotype 1 chronic hepatitis C (G1CHC) is generally accompanied by metabolic disturbances related to visceral obesity, such as insulin resistance, steatosis, or dyslipidemia. Because these abnormalities negatively influence the clinical course of G1CHC, we sought to clarify the effect of visceral obesity on the pathophysiology of G1CHC.
    Methods We evaluated 180G1CHC patients for the presence of visceral obesity on the basis of computed tomography findings. Multivariate analysis was performed to estimate the relationship between visceral obesity and demographic, viral, and biochemical characteristics of patients. The associations of visceral obesity with histological findings and serum adipokine levels were also analyzed.
    Results Multiple logistic regression analysis revealed that visceral obesity was independently associated with metabolic syndrome, platelet count, high-density lipoprotein level, and serum viral load in elderly patients (≥65 years). Multiple linear regression analysis confirmed the association between visceral obesity and high viral load. However, visceral obesity was not correlated with viral load in non-elderly patients (<65 years). Histological data (160 patients) demonstrated the significant association between visceral obesity and steatosis. Furthermore, patients with visceral obesity showed increase in the severity of fibrosis with advancing age. However, age-associated fibrosis progression was not evident in patients without visceral obesity. The serum adiponectin level was significantly low in patients with visceral obesity, whereas those of leptin, tumor necrosis factor-α, and interleukin-6 were not affected significantly.
    Conclusion Visceral obesity was associated with high viral load and histological damage in elderly patients with reduced adiponectin levels.
  • Hiroshi Kobayashi, Mineko Kinou, Kenji Takazawa
    2013 年 52 巻 15 号 p. 1675-1680
    発行日: 2013年
    公開日: 2013/08/01
    ジャーナル オープンアクセス
    Objective This study was designed to identify why the central blood pressure (cSBP) values obtained using the catheter method tend to be higher than brachial systolic blood pressure (bSBP) values obtained using the cuff method.
    Methods This study enrolled 20 patients who underwent coronary angiography (CAG) (mean age, 68.9 years; 13 men). Using the catheter method, a pressure guide wire was inserted via the radial artery at the time of CAG to measure the cSBP. The guide wire was then removed and the bSBP was obtained using two methods (the pressure guide wire method and the cuff method). The cSBP obtained with the catheter and the bSBP obtained with the cuff were compared, as were the bSBP obtained with the cuff and the bSBP obtained with the catheter.
    Results The cSBP obtained with the catheter was 4.6 mmHg higher than the bSBP obtained with the cuff. The bSBP obtained with the cuff was 8.3 mmHg lower than the bSBP obtained with the catheter. The cSBP obtained with the catheter was 1.7 mmHg lower than the bSBP obtained with the catheter.
    Conclusion In elderly patients with evident or suspected coronary heart disease, the finding of a higher cSBP measured using the catheter method than the bSBP obtained using the cuff method is attributable to bSBP underestimation (by 8.3 mmHg) using the cuff method compared to the bSBP directly obtained using the catheter method.
  • Eiko Takahashi, Kengo Moriyama, Minoru Yamakado
    2013 年 52 巻 15 号 p. 1681-1686
    発行日: 2013年
    公開日: 2013/08/01
    ジャーナル オープンアクセス
    Objective The Japan Atherosclerosis Society (JAS) has recommended serum lipid management goals (SLMGs) based on the coronary heart disease (CHD) risk classification included in its 2007 guidelines for the diagnosis and prevention of atherosclerotic cardiovascular disease in the Japanese population (JAS GL 2007). The Japan Society of Ningen Dock created a database of subjects receiving annual health examinations. Using this database, we evaluated the lifestyles of patients with dyslipidemia by identifying risk factors for CHD development based on the JAS recommendations.
    Methods A total of 223,407 adults (men: 138,435; women: 84,972) aged between 20 and 79 years were enrolled in the analysis. Those who were already being treated for dyslipidemia and had a history of CHD were excluded. CHD risk factors in the JAS GL 2007, such as an advanced age, hypertension, diabetes mellitus, smoking habits, a family history of coronary artery disease, and low high-density lipoprotein cholesterol levels, were used for the evaluation. The subjects were categorized into three groups (Categories I, II and III) according to the number of risk factors other than the low-density lipoprotein cholesterol (LDL-C) level. We evaluated the percentage of goals met during primary prevention in each group. The serum LDL-C levels were calculated using the Friedewald formula. The LDL-C levels were measured using a direct homogeneous assay if the triglyceride level was ≥400 mg/dL.
    Results Overall, 72.9% of the subjects achieved their SLMGs. Most subjects (>90%) with no CHD risk factors other than the LDL-C level in Category I achieved their SLMGs, while less than half of the subjects in Category III achieved their goal.
    Conclusion Smoking cessation and medication administration should be considered in patients in Categories II and III.
  • Chifumi Iseki, Yoshimi Takahashi, Manabu Wada, Toru Kawanami, Takeo Ka ...
    2013 年 52 巻 15 号 p. 1687-1690
    発行日: 2013年
    公開日: 2013/08/01
    ジャーナル オープンアクセス
    Objective We previously reported that, on brain MRI, iNPH features were observed in approximately 1% of asymptomatic elderly community dwellers. This phenomenon is designated asymptomatic ventriculomegaly with features of iNPH on MRI (AVIM). The aim of the present study was to clarify whether a subclinical decline in the neuropsychological function is present in patients with AVIM.
    Methods We examined eight subjects with AVIM, six subjects with possible iNPH and 21 elderly controls. Neuropsychological tests were used, including the mini-mental state examination (MMSE), the Hasegawa dementia scale-revised (HDS-R), the frontal assessment battery (FAB), the trail making test A&B and semantic and letter verbal fluency tests.
    Results When comparing the individuals with AVIM with the control subjects, significant differences were found in the scores achieved on the semantic verbal fluency tests and Luria's motor series (fist-edge-palm), a subtest of the FAB.
    Conclusion The present study suggests that individuals with AVIM demonstrate a slight subclinical decline in the cognitive function and motor regulation, which may represent a prodromal stage of iNPH.
  • Natsumi Furuta, Kouki Makioka, Yukio Fujita, Koichi Okamoto
    2013 年 52 巻 15 号 p. 1691-1696
    発行日: 2013年
    公開日: 2013/08/01
    ジャーナル オープンアクセス
    Objective To assess longitudinal changes in the clinical features of patients with amyotrophic lateral sclerosis (ALS), we performed a retrospective hospital-based study covering 35 years.
    Methods We investigated 287 patients (154 men and 133 women) with sporadic ALS hospitalized at the Department of Neurology at Gunma University Hospital (Japan) between 1978 and 2012. All patients fulfilled the diagnostic criteria for definitive, probable or laboratory-supported probable ALS according to the revised El Escorial criteria.
    Results Two hundred patients (69.7%) exhibited limb onset and 87 patients (30.3%) exhibited bulbar onset of the disease. The percentage of patients who showed bulbar onset of the disease increased steadily over the 35 years from 14.2% (1978-82) to 38.3% (2008-12) (p<0.01, r=0.470). The mean age at onset was 62.1 ± 11.7 years, and the age at onset increased significantly over time from 51.7 years (1978-82) to 64.9 years (2008-12) (p<0.001, r=0.294). In addition, the percentage of patients whose age at onset was 70 years or more increased from 0% (1978-82) to 38.2% (2008-12). The percentage of ALS patients with dementia increased from 0% (1978-82) to 20.2% (2008-12).
    Conclusion Our findings demonstrate that, among patients with sporadic ALS, the age at disease onset, the proportion of patients with disease onset at 70 years of age or higher, the proportion of patients with dementia and the proportion of patients with bulbar onset ALS have increased significantly over the past 35 years. The longitudinal changes observed in the clinical features of ALS may reflect the increasing age at disease onset.
CASE REPORTS
PICTURES IN CLINICAL MEDICINES
feedback
Top